Question 1

What are the potential side effects of CX-3543?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia clinical trial (NCT00485966). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia clinical trial (NCT00485966). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia clinical trial (NCT00485966). Contact the study team or your healthcare provider for specific answers.

Question 4

What tests will I need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia clinical trial (NCT00485966). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia clinical trial (NCT00485966). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or complications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia clinical trial (NCT00485966). Contact the study team or your healthcare provider for specific answers.

What this study is about